Market Research Logo

Fate Therapeutics, Inc. - Product Pipeline Review - 2016

Fate Therapeutics, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Fate Therapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Fate Therapeutics, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Fate Therapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Fate Therapeutics, Inc.
  • The report provides overview of Fate Therapeutics, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Fate Therapeutics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Fate Therapeutics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Fate Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Fate Therapeutics, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Fate Therapeutics, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Fate Therapeutics, Inc. Snapshot
Fate Therapeutics, Inc. Overview
Key Information
Key Facts
Fate Therapeutics, Inc. - Research and Development Overview
Key Therapeutic Areas
Fate Therapeutics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Fate Therapeutics, Inc. - Pipeline Products Glance
Fate Therapeutics, Inc. - Early Stage Pipeline Products
IND/CTA Filed Products/Combination Treatment Modalities
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Fate Therapeutics, Inc. - Drug Profiles
ProTmune
Product Description
Mechanism of Action
R&D Progress
Cellular Immunotherapy for Solid Tumors and Hematological Tumors
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy 2 for Undisclosed Indication
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Hearing Disorders
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Hematological and Solid Tumors
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Inflammation and Autoimmune Diseases
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Lysosomal Storage Disorder
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Solid Tumors and Hematologic Malignancies
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Musculoskeletal Disorders
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy 1 for Undisclosed Indication
Product Description
Mechanism of Action
R&D Progress
Fate Therapeutics, Inc. - Pipeline Analysis
Fate Therapeutics, Inc. - Pipeline Products by Molecule Type
Fate Therapeutics, Inc. - Recent Pipeline Updates
Fate Therapeutics, Inc. - Dormant Projects
Fate Therapeutics, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
FT-1050
Fate Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Fate Therapeutics, Inc., Key Information
Fate Therapeutics, Inc., Key Facts
Fate Therapeutics, Inc. - Pipeline by Indication, 2016
Fate Therapeutics, Inc. - Pipeline by Stage of Development, 2016
Fate Therapeutics, Inc. - Monotherapy Products in Pipeline, 2016
Fate Therapeutics, Inc. - Partnered Products in Pipeline, 2016
Fate Therapeutics, Inc. - Partnered Products/ Combination Treatment Modalities, 2016
Fate Therapeutics, Inc. - IND/CTA Filed, 2016
Fate Therapeutics, Inc. - Preclinical, 2016
Fate Therapeutics, Inc. - Discovery, 2016
Fate Therapeutics, Inc. - Pipeline by Molecule Type, 2016
Fate Therapeutics, Inc. - Recent Pipeline Updates, 2016
Fate Therapeutics, Inc. - Dormant Developmental Projects,2016
Fate Therapeutics, Inc. - Discontinued Pipeline Products, 2016
Fate Therapeutics, Inc., Subsidiaries
List of Figures
Fate Therapeutics, Inc. - Pipeline by Top 10 Indication, 2016
Fate Therapeutics, Inc. - Pipeline by Stage of Development, 2016
Fate Therapeutics, Inc. - Monotherapy Products in Pipeline, 2016
Fate Therapeutics, Inc. - Pipeline by Molecule Type, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report